European Commission 18 December 2019, Commission Decision of 18/12/2019 declaring a concentration to be compatible with the common market (Case No COMP/M.9331 - DANAHER / GE HEALTHCARE LIFE SCIENCES BIOPHARMA) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Also known as
European Union · · · Cited by 1 · 18-12-2019
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu. EUROPEAN COMMISSION Brussels, 18.12.2019 C(2019) 9429 final PUBLIC VERSION To the notifying party Subject: Case M.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (1 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit